Related Experiment Video
Updated: Jul 8, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
[Functional mapping of dopaminergic transmission]
1Human Brain Research Center, Kyoto University Graduate School of Medicine.
Rinsho Shinkeigaku = Clinical Neurology
|January 24, 2008
Summary
Parkinson's disease (PD) patients show impaired dopamine release in the striatum during working memory tasks. However, dopamine function appears preserved in the medial prefrontal cortex, suggesting specific dopaminergic pathway involvement in PD cognitive deficits.
Area of Science:
- Neuroscience
- Neurology
- Radiochemistry
Context:
- Cognitive impairments, including deficits in working memory and mental operations, are common in Parkinson's disease (PD).
- These cognitive deficits are hypothesized to stem from disruptions in dopaminergic pathways, specifically the nigrostriatal and mesocortical projections.
- Positron emission tomography (PET) with the D2 receptor antagonist 11C-raclopride (RAC) offers an in vivo method to assess dopaminergic transmission during cognitive tasks.
Purpose:
- To investigate in vivo dopamine release in the striatum and medial prefrontal cortex during a working memory task in patients with Parkinson's disease.
- To correlate in vivo dopaminergic transmission with cognitive performance in PD.
- To elucidate the role of specific dopaminergic pathways in PD-related cognitive dysfunction.
Summary:
- Patients with Parkinson's disease exhibited significantly impaired dopamine release in the striatum during a working memory task, as measured by 11C-raclopride (RAC) PET.
- In contrast, dopamine release in the medial prefrontal cortex was relatively preserved in PD patients during the same task.
- These findings align with previous H2(15)O PET studies showing striatal hypoactivity during mental operations in PD.
Impact:
- The study supports the hypothesis that degeneration of the nigrostriatal dopaminergic projection and subsequent disruption of the cortico-basal ganglia circuit contribute to cognitive impairments in Parkinson's disease.
- The findings suggest that mesocortical dopaminergic function may remain relatively intact in PD.
- These results have implications for dopamine replacement therapy, highlighting the need to balance potential benefits in the striatum against risks of overstimulation in the frontal cortex.
Related Concept Videos
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:30Classification of Neurotransmitters
Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...
01:29Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...